Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
3.85M
-
Shares change
-
+260K
-
Total reported value, excl. options
-
$97.7M
-
Value change
-
+$14.4M
-
Number of buys
-
30
-
Number of sells
-
-19
-
Price
-
$25.40
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q4 2019
50 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q4 2019.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.85M shares
of 22M outstanding shares and own 17.45% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (719K shares), FARALLON CAPITAL MANAGEMENT LLC (578K shares), PRICE T ROWE ASSOCIATES INC /MD/ (478K shares), VICTORY CAPITAL MANAGEMENT INC (388K shares), WASATCH ADVISORS INC (351K shares), NEXT CENTURY GROWTH INVESTORS LLC (261K shares), VANGUARD GROUP INC (245K shares), CALAMOS ADVISORS LLC (217K shares), BlackRock Inc. (122K shares), and Russell Investments Group, Ltd. (115K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.